phentolamine has been researched along with Parkinson Disease in 3 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imura, H | 1 |
| Nakai, Y | 1 |
| Matsukura, S | 1 |
| Matsuyama, H | 1 |
| Kansal, PC | 1 |
| Buse, J | 1 |
| Talbert, OR | 1 |
| Buse, MG | 1 |
| Hunter, KR | 1 |
| Boakes, AJ | 1 |
| Laurence, DR | 1 |
| Stern, GM | 1 |
3 other studies available for phentolamine and Parkinson Disease
| Article | Year |
|---|---|
Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
Topics: Adult; Aged; Anorexia Nervosa; Blood Glucose; Central Nervous System Diseases; Dihydroxyphenylalanin | 1973 |
The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
Topics: Administration, Oral; Aged; Animals; Blood Glucose; Dihydroxyphenylalanine; Female; Growth Hormone; | 1972 |
Monoamine oxidase inhibitors and L-dopa.
Topics: Blood Pressure; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypertension; Male; Middle Aged; Par | 1970 |